1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183–192
2. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: The Nippon COPD Epidemiology study. Respirology 2004;9:458–465
3. Cigarette Smoking and Health. Am J Respir Crit Care Med 2005;19:173–177
4. Summary E. American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900
5. Cho MH, McDonald MLN, Zhou X, et al. Risk loci for chronic obstructive pulmonary disease: A genome-wide association study and meta-analysis. Lancet Respir Med 2014;2:214–225
6. Sakornsakolpat P, Prokopenko D, Lamontagne M, et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat Genet 2019;51:494–505
7. Gharib SA, Manicone AM, Parks WC. Matrix metalloproteinases in emphysema. Matrix Biol 2018;73:34–51
8. Elkington PTG, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006;61:259–266
9. Chaudhuri R, McSharry C, Brady J, et al. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severity. J Allergy Clin Immunol 2012;129:655-663.e8
10. Finlay GA, O’Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997;156:240–247
11. Molet S, Belleguic C, Lena H, et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005;54:31–36
12. Babusyte A, Stravinskaite K, Jeroch J, et al. Patterns of airway inflammation and MMP- 12 expression in smokers and ex-smokers with COPD. Respir Res 2007;8:1–9
13. Gary M. Hunninghake, M.D., M.P.H., Michael H. Cho, M.D., M.P.H., Yohannes Tesfaigzi PD. MMP12, Lung Function, and COPD in High-Risk Populations. N Engl J Med 2009;361:2599–2608
14. Hautamaki RD, Kobayashi DK, Senior RM, et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (80- ) 1997;277:2002–2004
15. Shibata S, Miyake K, Tateishi T, et al. Basophils trigger emphysema development in a murine model of COPD through IL-4–mediated generation of MMP-12–producing macrophages. Proc Natl Acad Sci 2018;115:13057–13062
16. Yamasaki K, Van Eeden SF. Lung macrophage phenotypes and functional responses: Role in the pathogenesis of COPD. Int J Mol Sci 2018;19:1–12
17. Liegeois M, Legrand C, Desmet CJ, et al. The interstitial macrophage: A long-neglected piece in the puzzle of lung immunity. Cell Immunol 2018;330:91–96
18. Quesada Calvo F, Vanderplasschen A, Lekeux P, et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest 2009;119:3723–3738
19. Sabatel C, Radermecker C, Fievez L, et al. Exposure to Bacterial CpG DNA Protects from Airway Allergic Inflammation by Expanding Regulatory Lung Interstitial Macrophages. Immunity 2017;46:457–473
20. Gibbings SL, Thomas SM, Atif SM, et al. Three unique interstitial macrophages in the murine lung at steady state. Am J Respir Cell Mol Biol 2017;57:66–76
21. Chakarov S, Lim HY, Tan L, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science (80- ) 2019;363:
22. Xue J, Schmidt S V., Sander J, et al. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation. Immunity 2014;40:274–288
23. Aldonyte R, Jansson L, Piitulainen E, et al. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003;4:1–8
24. Kapellos TS, Bassler K, Aschenbrenner AC, et al. Dysregulated functions of lung macrophage populations in COPD. J Immunol Res 2018;2018:
25. Ni L, Dong C. Roles of myeloid and lymphoid cells in the pathogenesis of chronic obstructive pulmonary disease. Front Immunol 2018;9:1–12
26. Berenson CS, Garlipp MA, Grove LJ, et al. Impaired Phagocytosis of Nontypeable Haemophilus influenzae by Human Alveolar Macrophages in Chronic Obstructive Pulmonary Disease . J Infect Dis 2006;194:1375–1384
27. Hiemstra PS. Altered macrophage function in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013;10:
28. Arora S, Dev K, Agarwal B, et al. Macrophages: Their role, activation and polarization in pulmonary diseases. Immunobiology 2018;223:383–396
29. Facchinetti F, Amadei F, Geppetti P, et al. Α,Β-Unsaturated Aldehydes in Cigarette Smoke Release Inflammatory Mediators From Human Macrophages. Am J Respir Cell Mol Biol 2007;37:617–623
30. Doyle AD, Mukherjee M, LeSuer WE, et al. Eosinophil-derived IL-13 Promotes Emphysema. Eur Respir J 2019;1801291doi:10.1183/13993003.01291-2018.
31. Ravetch J V. Immune Inhibitory Receptors. Science (80- ) 2002;290:84–89
32. van der Touw W, Chen HM, Pan PY, et al. LILRB receptor-mediated regulation of myeloid cell maturation and function. Cancer Immunol Immunother 2017;66:1079–1087
33. Shik D, Munitz A. Regulation of allergic inflammatory responses by inhibitory receptors. Clin Exp Allergy 2010;40:700–709
34. McKendry RT, Spalluto CM, Burke H, et al. Dysregulation of antiviral function of CD81 T cells in the chronic obstructive pulmonary disease lung role of the PD-1-PD-L1 axis. Am J Respir Crit Care Med 2016;193:642–651
35. Kalathil SG, Lugade AA, Pradhan V, et al. T-regulatory cells and programmed death 1+ T cells contribute to effector T-Cell dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;190:40–50
36. Katz HR. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors. Immunol Rev 2007;217:222–230
37. Cella BM, Döhring C, Samaridis J, et al. A Novel Inhibitory Receptor ( ILT3 ) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing. J Exp Med 1997;185:1743–1751
38. Inui M, Sugahara-Tobinai A, Fujii H, et al. Tolerogenic immunoreceptor ILT3/LILRB4 paradoxically marks pathogenic auto-antibodyproducing plasmablasts and plasma cells in non-treated SLE. Int Immunol 2016;28:597–604
39. Lu Y, Jiang Z, Dai H, et al. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. Hepatology 2018;67:1303–1319
40. Deng M, Gui X, Kim J, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature 2018;562:605–609
41. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by Ts cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3:237–243
42. Fanning LB, Buckley CC, Xing W, et al. Downregulation of Key Early Events in the Mobilization of Antigen-bearing Dendritic Cells by Leukocyte Immunoglobulin-like Receptor B4 in a Mouse Model of Allergic Pulmonary Inflammation. PLoS One 2013;8:
43. Ulges A, Klein M, Reuter S, et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat Immunol 2015;16:267–275
44. de Goeje PL, Bezemer K, Heuvers ME, et al. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer. Oncoimmunology 2015;4:1–11
45. Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol 1982;33:379–387
46. Yu YRA, Hotten DF, Malakhau Y, et al. Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues. Am J Respir Cell Mol Biol 2016;54:13–24
47. Kasai S, Inui M, Nakamura K, et al. A novel regulatory role of gp49B on dendritic cells in T-cell priming. Eur J Immunol 2008;38:2426–2437
48. Moro K, Ealey KN, Kabata H, et al. Isolation and analysis of group 2 innate lymphoid cells in mice. Nat Protoc 2015;10:792–806
49. Yu YRA, O’Koren EG, Hotten DF, et al. A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLoS One 2016;11:1–23
50. Dewhurst JA, Lea S, Hardaker E, et al. Characterisation of lung macrophage subpopulations in COPD patients and controls. Sci Rep 2017;7:1–12
51. Kobayashi S, Fujinawa R, Ota F, et al. A single dose of lipopolysaccharide into mice with emphysema mimics human Chronic obstructive pulmonary disease exacerbation as assessed by micro-computed tomography. Am J Respir Cell Mol Biol 2013;49:971–977
52. Lucey EC, Keane J, Kuang PP, et al. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-α and interleukin-1β receptor-deficient mice. Lab Investig 2002;82:79–85
53. Demirjian L, Abboud RT, Li H, et al. Acute effect of cigarette smoke on TNF-α release by macrophages mediated through the erk1/2 pathway. Biochim Biophys Acta - Mol Basis Dis 2006;1762:592–597
54. Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005;32:311–318
55. Churg A, Zhou S, Wright JL. Matrix metalloproteinases in COPD. Eur Respir J 2012;39:197–209
56. Nakagomi D, Suzuki K, Meguro K, et al. Matrix metalloproteinase 12 is produced by M2 macrophages and plays important roles in the development of contact hypersensitivity. J Allergy Clin Immunol 2015;135:1397–1400
57. Haque SJ, Harbor P, Tabrizi M, et al. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem 1998;273:33893–33896
58. Sapey E, Ahmad A, Bayley D, et al. Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol 2009;29:508– 516